Market Cap: $3.76B
PI
Pulse Biosciences, Inc.
PLSE
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $3.76B
Pulse Biosciences (Ticker: PLSE) implements a significant strategic decision as it moves to redeem the remaining common stock warrants from its rights offering dated July 3, 2024. This action comes in…
Operational Scorecard in Focus at Pulse Biosciences Pulse Biosciences is set to release its quarterly report on Feb. 19, and the company frames the announcement as an operational scorecard for its bio…
Pulse Biosciences: Innovative Advancements in Bioelectric Therapy Pulse Biosciences is making significant strides in the field of bioelectric therapy, positioning itself as a leader in the development…
Pulse Biosciences: Advancements in Market Presence and Innovation Pulse Biosciences, a leader in the field of bioelectronic medicine, is making significant strides in expanding its market presence and…
Pulse Biosciences: Harnessing Innovative Technology in Healthcare Pulse Biosciences is at the forefront of a transformative approach to healthcare, leveraging its innovative platform to enhance treatm…
Pulse Biosciences Unveils Promising Data on Nanosecond PFA Catheter for Atrial Fibrillation Treatment Pulse Biosciences, Inc. presents significant findings from a first-in-human feasibility study invo…
Pulse Biosciences to Showcase Groundbreaking nsPFA Technology at AF Symposium 2025 Pulse Biosciences, Inc. is set to present its innovative Nanosecond Pulsed Field Ablation™ (nsPFA™) technology at the…
Pulse Biosciences to Showcase Groundbreaking Technology at Upcoming AF Symposium Pulse Biosciences, Inc., a Miami-based company, announces the upcoming presentation of its proprietary Nanosecond Pulse…
Pulse Biosciences Appoints New Leadership to Propel Medical Innovations Pulse Biosciences, Inc. (Nasdaq: PLSE) takes a significant step forward by appointing Paul A. LaViolette as its new Chief Execut…
Pulse Biosciences Showcases Innovative Technology at J.P. Morgan Healthcare Conference Pulse Biosciences, Inc., a pioneering bioelectric medicine company based in Miami, Florida, prepares to present i…
Pulse Biosciences Moves Forward with Warrant Redemption Plan Pulse Biosciences, Inc. announces a significant step in its capital strategy with an irrevocable notice of redemption for its first tranche…
Pulse Biosciences Advances Nonthermal Treatment for Thyroid Nodules Pulse Biosciences, Inc. (Nasdaq: PLSE) showcases significant advancements in the treatment of benign thyroid nodules with the prelim…
Pulse Biosciences Fortifies Leadership to Accelerate Electrophysiology Innovations Pulse Biosciences, Inc. strengthens its clinical leadership team with the recent appointment of Dr. David Kenigsberg…